-
1 week ago | 
buff.ly | Amerigo Allegretto |Edna Astbury-Ward |Philip Ward |Maryam Payne
The Italian Society of Medical and Interventional Radiology (SIRM) joined forces with other medical associations from 10 to 14 June in Italy’s northwest coastal region of Liguria to boost awareness of cancer prevention. Society members gathered with the Italian Association of Medical Oncology, the AIRC Foundation, and the AIOM Foundation in Genoa at the “Villaggio Italia” (Calata Mandraccio) in the final stage of the Vespucci World Tour.
-
1 week ago | 
buff.ly | Edna Astbury-Ward |Philip Ward |Amerigo Allegretto |Maryam Payne
Volumetric body composition metrics is a rapidly emerging technique and can be a strong indicator of survival in patients with colorectal cancer (CRC), a study published on 14 June in the European Journal of Radiology has found. The relationship between the two is complex, however, and conventional approaches may not provide a comprehensive assessment, according to a team from the Departments of Cancer Epidemiology and Breast Oncology at the H.
-
2 weeks ago | 
buff.ly | Will Morton |Maryam Payne |Liz Carey |Edna Astbury-Ward
A radiologist, his pathologist wife, and their three children have been named among the 240-plus victims of the Air India plane crash, according to a report posted by BBC News on 13 June.
-
2 weeks ago | 
buff.ly | Liz Carey |Amerigo Allegretto |Maryam Payne |Edna Astbury-Ward
Liver cirrhosis results in cardiac changes that are more extensive than previously established, according to a study published on 5 June in European Radiology. Despite preoperative screening, cardiac-associated death remains a leading cause of post-transplant mortality in cirrhosis patients, explained Dr. Jennifer Erley and colleagues in the Department of Diagnostic and Interventional Radiology and Nuclear Medicine at the University Medical Center Hamburg-Eppendorf, Germany.
-
2 months ago | 
auntminnieeurope.com | Will Morton |Philip Ward |Edna Astbury-Ward
The European Association of Nuclear Medicine (EANM) has added 50 spots in its initiative to support the younger generation of nuclear medicine professionals, the Next-Gen Program. Accepted applicants (under the age of 39) will receive free registration, free accommodation, and specific opportunities to network at the association’s 2025 annual meeting to be held from 4 to 8 October in Barcelona, Spain. Last year, EANM received 600 applications for 100 spots, and is offering 150 spots this year.
-
2 months ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
German radiotheranostics company Navigo Proteins has entered a strategic research collaboration with SCK CEN, a Belgian nuclear research center. The partnership will focus on the preclinical development of next-generation radiotheranostics cancer treatments using the radioisotope terbium-161 (Tb-161). Navigo has developed carrier molecules, while SCK CEN provides Tb-161, infrastructure, and expertise in preclinical testing.
-
2 months ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
German radiotheranostics company Navigo Proteins has entered a strategic research collaboration with SCK CEN, a Belgian nuclear research center. The partnership will focus on the preclinical development of next-generation radiotheranostics cancer treatments using the radioisotope terbium-161 (Tb-161). Navigo has developed carrier molecules, while SCK CEN provides Tb-161, infrastructure, and expertise in preclinical testing.
-
2 months ago | 
auntminnieeurope.com | Will Morton |Philip Ward |Edna Astbury-Ward
The European Association of Nuclear Medicine (EANM) has added 50 spots in its initiative to support the young generation of nuclear medicine professionals, the Next-Gen Program. Accepted applicants (under the age of 39) will receive free registration, free accommodation, and specific opportunities to network at the association’s 2025 annual meeting to be held from 4 to 8 October in Barcelona, Spain. Last year, EANM received 600 applications for 100 spots, and is offering 150 spots this year.
-
2 months ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
Radiotherapy developer Actinium Pharmaceuticals is launching ATNM-400, a novel, non-prostate-specific membrane antigen (PSMA) targeting radiotherapy for prostate cancer that uses the actinium-225 (Ac-225) radioisotope. Initial preclinical data from a study on ATNM-400's performance will be presented at the American Association for Cancer Research (AACR) annual meeting being held between 25 and 30 April 25 in Chicago.
-
2 months ago | 
auntminnieeurope.com | Erik L. Ridley |Amerigo Allegretto |Philip Ward |Edna Astbury-Ward
AI could help sonographers find fetal abnormalities faster without sacrificing diagnostic quality, according to research published on 27 March in the New England Journal of Medicine. A team led by Thomas Day, PhD, from King’s College London in the U.K., found that AI sped up scan times by more than eight minutes and achieved high marks in detecting fetal malformations.
